[go: up one dir, main page]

MX2016012372A - Composiciones inmunologicas que contienen histophilus somni atenuado. - Google Patents

Composiciones inmunologicas que contienen histophilus somni atenuado.

Info

Publication number
MX2016012372A
MX2016012372A MX2016012372A MX2016012372A MX2016012372A MX 2016012372 A MX2016012372 A MX 2016012372A MX 2016012372 A MX2016012372 A MX 2016012372A MX 2016012372 A MX2016012372 A MX 2016012372A MX 2016012372 A MX2016012372 A MX 2016012372A
Authority
MX
Mexico
Prior art keywords
histophilus somni
compositions containing
immunological compositions
strains
attenuated histophilus
Prior art date
Application number
MX2016012372A
Other languages
English (en)
Other versions
MX373361B (es
Inventor
Kolander Tammy
Lawrence Paulraj
Bey Russell
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of MX2016012372A publication Critical patent/MX2016012372A/es
Publication of MX373361B publication Critical patent/MX373361B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Esta descripción proporciona cepas de Histophilus somni atenuadas, composiciones que las comprenden, y métodos de producción y uso de las mismas. Las cepas atenuadas pueden expresar niveles menores o ninguno de varios genes asociados con virulencia, con relación a las bacterias patogénicas correspondientes. Ventajosamente, las cepas de Histophilus somni atenuadas se pueden administrar oralmente, intranasalmente, intra-traquealmente o subcutáneamente.
MX2016012372A 2014-03-25 2015-03-25 Composiciones inmunológicas que contienen histophilus somni atenuado. MX373361B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461970195P 2014-03-25 2014-03-25
PCT/US2015/022519 WO2015148687A2 (en) 2014-03-25 2015-03-25 Immunological compositions containing attenuated histophilus somni

Publications (2)

Publication Number Publication Date
MX2016012372A true MX2016012372A (es) 2017-05-30
MX373361B MX373361B (es) 2020-05-25

Family

ID=52829377

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012372A MX373361B (es) 2014-03-25 2015-03-25 Composiciones inmunológicas que contienen histophilus somni atenuado.

Country Status (19)

Country Link
US (2) US9592283B2 (es)
EP (2) EP3122374B1 (es)
JP (1) JP6405390B2 (es)
KR (1) KR101924271B1 (es)
CN (1) CN107197626B (es)
AU (1) AU2015236052B2 (es)
BR (1) BR112016021918A2 (es)
CA (1) CA2943786C (es)
CL (1) CL2016002402A1 (es)
DK (1) DK3488862T3 (es)
EA (1) EA038530B1 (es)
ES (1) ES2927971T3 (es)
HU (1) HUE059284T2 (es)
MX (1) MX373361B (es)
NZ (1) NZ724908A (es)
PH (1) PH12016501879A1 (es)
PL (1) PL3488862T3 (es)
TR (1) TR201907352T4 (es)
WO (1) WO2015148687A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3488862T3 (da) * 2014-03-25 2022-08-01 Boehringer Ingelheim Animal Health Usa Inc Immunologiske sammensætninger indeholdende svækket histophilus somni
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
PT3652215T (pt) 2017-07-14 2021-05-18 Immatics Biotechnologies Gmbh Molécula de polipéptido com especificidade dupla melhorada
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins
JP7535896B2 (ja) * 2020-09-10 2024-08-19 株式会社Fuji 検出装置、作業機および検出方法
RU2754005C1 (ru) * 2020-10-29 2021-08-25 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук" (ФГБНУ ФНЦ ВИЭВ РАН) Штамм бактерий histophilus somni, предназначенный для получения моно- и поливалентных иммуногенных композиций, направленных на специфическую профилактику гистофилеза (стадного бесплодия) рогатого скота
IL308257A (en) 2021-05-05 2024-01-01 Immatics Biotechnologies Gmbh Antigen binding proteins that uniquely bind PRAME
CN113174374B (zh) * 2021-05-19 2022-07-22 西南民族大学 一种牛病毒性腹泻病毒弱毒株及其用途
CN118956701B (zh) * 2024-10-16 2025-02-11 金宇保灵生物药品有限公司 一种昏睡嗜血杆菌菌株及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60500673A (ja) 1983-03-08 1985-05-09 コモンウエルス　セラム　ラボラトリ−ズ　コミツシヨン 抗原活性を有するアミノ酸配列
US6610661B1 (en) 1996-10-11 2003-08-26 The Regents Of The University Of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
US6770273B1 (en) * 1998-09-25 2004-08-03 Regents Of The University Of California Vaccine based on attenuated Haemophilus somnus
CA2347278C (en) * 1998-09-25 2007-07-17 Lynette B. Corbeil Vaccine based on attenuated haemophilus somnus
UY29915A1 (es) * 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
CA2729080C (en) * 2008-07-03 2018-09-11 Ricardo Rosenbusch Cattle vaccines
US9597386B2 (en) * 2012-04-05 2017-03-21 Boehringer Ingelheim Vetmedica, Inc. Outer membrane proteins of Histophilus somni and methods thereof
WO2015066292A1 (en) * 2013-11-01 2015-05-07 Merial Limited Attenuated pasteurella multocidavaccines & methods of making & use thereof
DK3488862T3 (da) * 2014-03-25 2022-08-01 Boehringer Ingelheim Animal Health Usa Inc Immunologiske sammensætninger indeholdende svækket histophilus somni

Also Published As

Publication number Publication date
DK3488862T3 (da) 2022-08-01
US10098941B2 (en) 2018-10-16
JP2017517245A (ja) 2017-06-29
US20150273045A1 (en) 2015-10-01
PH12016501879B1 (en) 2017-01-09
AU2015236052A1 (en) 2016-11-10
WO2015148687A3 (en) 2015-12-23
PL3488862T3 (pl) 2022-08-29
BR112016021918A2 (pt) 2017-10-24
TR201907352T4 (tr) 2019-06-21
WO2015148687A2 (en) 2015-10-01
MX373361B (es) 2020-05-25
EP3488862B1 (en) 2022-05-04
EA038530B1 (ru) 2021-09-10
CN107197626B (zh) 2021-03-02
CL2016002402A1 (es) 2017-05-26
ES2927971T3 (es) 2022-11-14
EP3122374B1 (en) 2019-02-20
US20170157232A1 (en) 2017-06-08
EP3122374A2 (en) 2017-02-01
KR101924271B1 (ko) 2019-02-22
CA2943786A1 (en) 2015-10-01
CN107197626A (zh) 2017-09-22
HUE059284T2 (hu) 2022-11-28
CA2943786C (en) 2023-12-12
US9592283B2 (en) 2017-03-14
EP3488862A1 (en) 2019-05-29
EA201691915A1 (ru) 2017-04-28
AU2015236052B2 (en) 2018-05-10
KR20160128427A (ko) 2016-11-07
NZ724908A (en) 2017-12-22
PH12016501879A1 (en) 2017-01-09
JP6405390B2 (ja) 2018-10-17

Similar Documents

Publication Publication Date Title
MX2016012372A (es) Composiciones inmunologicas que contienen histophilus somni atenuado.
EA201990566A1 (ru) Композиции, содержащие бактериальные штаммы
WO2016033439A3 (en) Compositions and methods for the treating an inflammatory disease or disorder
CL2016001235A1 (es) Cepa bacteriana aislada del genero burkholderia y metabolitos plaguicidas derivados-formulaciones y usos (divisional solicitud 467-2014).
EA201291157A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
MX2015013202A (es) Cultivo, produccion, procesamiento y uso de cannabis de especialidad.
TWD170026S (zh) 容器
AR091582A1 (es) Vacunas atenuadas contra streptococcus suis y metodos de elaboracion y uso de las mismas
MY191539A (en) Streptococcal vaccine
SG11201705667UA (en) Culture product of microorganism belonging to the genus wickerhamomyces
MX2017016401A (es) Composiciones inmunogenas.
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
CL2016002223A1 (es) Microorganismo recombinante que expresa análogos de avermectina y uso de los mismos.
MX393266B (es) Composiciónpara usarse en terapia de microbiota
MX2021006458A (es) Pared celular de levadura enriquecida en proteina de manano-oligosacarido.
PH12019501173A1 (en) Attenuated swine influenza vaccines and methods of making and use thereof
CL2016000672A1 (es) Bacteria aislada del género streptomyces
CL2018001680A1 (es) Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum
MX2018014532A (es) Un metodo para reducir la contaminacion de los huevos.
BR112019003112A2 (pt) bactérias
WO2015169773A3 (en) Mutants of spy0269
UY35631A (es) ?composición de solución de rehidratación oral que contiene probióticos?.
RU2016151496A (ru) Штамм бактерий corynebacterium krestovnikova - troitskaya, используемый для приготовления иммуностимулятора

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.

FG Grant or registration